Sever Pharma Solutions appoints new CEO
Fredrik Hultenius has been a vital member of the Sever Pharma Solutions team since 2021, initially leading production and site operations in Malmö before advancing to Vice President of Operations with global responsibilities.
“We are excited about the leadership and operational expertise Fredrik brings to the role of CEO,” says Sean Davis, CEO of Sever Life Science. “His ability to lead teams, collaborate effectively with external partners, and drive strategic business development will be pivotal in achieving our ambitious growth goals.”
Fredrik Hultenius
Fredrik Hultenius brings over a decade of experience in the pharmaceutical and medical device industries, previously holding roles at Baxter International and Tetra Pak. His background underscores his proven ability to manage teams, drive operational efficiency, and foster continuous improvement, states the company.
Fredrik holds an M.Sc. in Production Engineering and a B.Sc. in Mechanical Engineering.
Updated: August 14, 2025, 10:30 am
Published: August 1, 2025
